Liu Jia, Mittendorf Thomas, von der Schulenburg J-Matthias
Center for Health Economics, Leibniz University Hannover, Hannover, Germany.
Cancer Invest. 2010 Mar;28(3):312-22. doi: 10.3109/07357900903287022.
Aim of this paper is to review and describe Health-Related Quality of Life (HRQoL) measures applied in kidney cancer, hepatocellular carcinoma, and leukemia patients under drug therapy. A comprehensive search in PubMed was conducted to identify studies assessing quality of life (QoL) in these indications. In total 32 studies, including four studies through reference list checking and 21 different HRQoL instruments, were identified. Six generic, five disease-specific, and 10 domain-specific instruments were identified. In conclusion no overall standards in HRQoL measurement could be observed in the respective indications.
本文旨在回顾和描述药物治疗下肾癌、肝细胞癌和白血病患者所应用的健康相关生活质量（HRQoL）测量方法。在PubMed中进行了全面检索，以识别评估这些适应症患者生活质量（QoL）的研究。总共识别出32项研究，包括通过参考文献检查的4项研究以及21种不同的HRQoL工具。识别出6种通用工具、5种疾病特异性工具和10种领域特异性工具。总之，在各自的适应症中未观察到HRQoL测量的总体标准。
